Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionCwm, Llc
Latest Disclosed Ownership15,579 shares
Latest Disclosed Value $ 469,254
Cwm, Llc reports 108.78% increase in ownership of TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 14, 2026 - Cwm, Llc filed a 13F-HR form disclosing ownership of 15,579 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $469,239 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 7,462 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). The current value of the position is $511,459 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 15,579 8,117 108.78 469 0.0012
2026-01-26 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 7,462 2,101 39.19 0 0.0006
2025-10-15 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 5,361 366 7.33 0 0.0003
2025-07-25 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 4,995 767 18.14 0 0.0003
2025-05-01 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 4,228 148 3.63 0 0.0003
2025-02-04 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 4,080 -112 -2.67 0 0.0004
2024-10-08 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 4,192 126 3.10 0 0.0003
2024-07-10 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 4,066 395 10.76 0 0.0003
2024-04-05 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 3,671 420 12.92 0 0.0003
2024-02-01 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 3,251 362 12.53 0 0.0002
2023-10-11 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,889 896 44.96 0 0.0002
2023-08-03 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,993 -95 -4.55 0 0.0001
2023-05-01 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,088 -102 -4.66 0 0.0001
2023-02-01 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,190 163 8.04 0 -100.00 0.0001
2022-10-27 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,027 204 11.19 16 14.29 0.0001
2022-07-28 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,823 200 12.32 14 -6.67 0.0001
2022-04-21 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,623 -147 -8.31 15 7.14 0.0001
2022-01-31 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,770 665 60.18 14 27.27 0.0001
2021-09-15 2021-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 0.00 11 0.00 0.0001
2021-07-29 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 11 0.0001
2021-09-15 2021-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 0.00 11 0.00 0.0001
2021-04-27 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,705 600 20 0.0002
2021-09-15 2020-12-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 0.00 11 0.00 0.0001
2021-01-27 2020-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,125 20 11 0.0001
2021-09-15 2020-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 0.00 11 0.00 0.0001
2020-10-19 2020-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,450 345 13 0.0001
2021-09-15 2020-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 0.00 11 0.00 0.0001
2020-07-22 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,568 463 19 0.0002
2021-09-15 2020-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 0.00 11 0.00 0.0001
2020-04-28 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,237 1,132 20 0.0003
2021-09-14 2019-12-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 0.00 11 0.00 0.0001
2020-01-27 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,081 -24 11 0.0001
2021-09-14 2019-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 0.00 11 0.00 0.0001
2019-10-22 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,317 1,212 16 0.0002
2021-09-14 2019-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 0 0.00 11 0.00 0.0001
2019-07-31 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,536 1,431 23 0.0004
2021-09-02 2019-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,105 -6,433 -85.34 11 -90.52 0.0001
2019-04-22 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 2,536 -5,002 40 0.0008
2019-01-25 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 7,538 1,236 19.61 116 -14.71 0.0029
2018-10-29 2018-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 6,302 6,300 315,000.00 136 0.0035
2018-07-31 2018-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 2 -63 -96.92 0 -100.00
2018-04-26 2018-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 65 -2 -2.99 1 0.00 0.0000
2018-01-16 2017-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 67 -300 -81.74 1 -83.33 0.0000
2017-10-16 2017-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 367 -4,244 -92.04 6 -96.08 0.0003
2017-07-17 2017-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 4,611 -1,400 -23.29 153 -20.73 0.0078
2017-04-17 2017-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 6,011 -58,050 -90.62 193 -91.69 0.0109
2017-01-19 2016-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 64,061 652 1.03 2,322 -20.40 0.1423
2016-10-17 2016-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 63,409 24,400 62.55 2,917 48.90 0.2013
2016-07-21 2016-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 39,009 39,009 0.00 1,959 0.1429
2016-04-18 2016-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 0 -136 -100.00 0 -100.00
2016-02-01 2015-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 136 -79 -36.74 9 -25.00 0.0009
2015-10-30 2015-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 215 215 12 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.